Prostate cancer is the second most common cancer in men, posing a significant public health concern. While MRI scans are vital for early detection and appropriate management, the increased demand for scans has outpaced the growth of radiologists. This has resulted in diagnostic delays and inconsistent interpretations.

Quibim presents QP-Prostate, an AI-powered solution designed to streamline radiologists’ workflows. QP-Prostate integrates seamlessly with the hospital's PACS and provides an automatic detection for clinically significant prostate cancer lesions, as well as an automatic prostate segmentation and volume calculation.

QP-Prostate empowers radiologists to deliver quicker and more accurate assessments, ultimately enhancing patient care. 

QP-Prostate

avaldaja Quibim